Inovio Pharmaceuticals Inc. (INO) |
|
21.45 1.72 (8.72%)
|
07-02 16:00 |
|
Open: |
19.91 |
Pre. Close: |
19.73 |
|
High:
|
22.4599 |
Low:
|
19.9 |
|
Volume:
|
52,201,682 |
Market Cap:
|
3,391M |
|
|
|
|
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat, cure, and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance of cancerous cells and facilitate cross-strain protection against unmatched and matched pathogens. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
22.492 - 22.618 |
22.618 - 22.733 |
|
Low:
|
19.597 - 19.747 |
19.747 - 19.885 |
|
Close:
|
21.219 - 21.45 |
21.45 - 21.662 |
|
Technical analysis |
as of: 2020-07-02 4:31:26 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time. |
| Target: |
Six months: 29.36 One year: 39.47 |
| Support: |
Support1: 11.13 Support2: 9.26 |
| Resistance: |
Resistance1: 25.13 Resistance2: 33.79 |
| Pivot: |
20.35 |
| Moving Average: |
MA(5): 25.96  MA(20): 18.38
MA(100): 11.05 MA(250): 6.04 |
| MACD: |
MACD(12,26): 3.28 Signal(9): 2.87 |
| Stochastic oscillator: |
%K(14,3): 48.63 %D(3): 64.72 |
| RSI: |
RSI(14): 54.73 |
| 52-week: |
High: 33.79 Low: 1.92 Change(%): 619.8 |
| Average Vol(K): |
3-Month: 4176667 10-Days: 9316908 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.INO has closed below upper band by 45.9%. Bollinger Bands are 299% wider than normal. The large width of the bands suggest high volatility as compared to INO's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Sat, 04 Jul 2020
Inovio Stock: Buy, Sell, or Hold? - Motley Fool
Fri, 03 Jul 2020
Inovio Pharmaceuticals Inc. (INO) Shares have surged over 11.07 as It Announces Positive Interim Phase 1 Data of Potential Vaccine for COVID-19 - Frisco Herald
Thu, 02 Jul 2020
The Rejuvenation of Inovio Pharmaceuticals Inc. (NASDAQ:INO) - The Oracle Dispatch
Thu, 02 Jul 2020
$18.35 – $24.27: is It Good Range to Buy Inovio Pharmaceuticals, Inc. (INO)? - The News Heater
Wed, 01 Jul 2020
How Does Inovio Pharmaceuticals Inc (INO) Stock Rank in the Healthcare Sector? - InvestorsObserver
Tue, 30 Jun 2020
Why Inovio Pharmaceuticals Plunged 20% Today - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: Nasdaq Global Select |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
158 |
| Shares Float (M) |
155 |
|
% Held by Insiders
|
2.69 |
|
% Held by Institutions
|
29.41 |
|
Shares Short (K)
|
25,780 |
|
Shares Short P. Month (K)
|
22,920 |
Stock Financials |
|
EPS
|
-1.160 |
|
EPS Est This Year
|
-0.950 |
|
EPS Est Next Year
|
-1.200 |
|
Book Value (p.s.)
|
1.260 |
|
Profit Margin
|
|
|
Operating Margin
|
-4058.78 |
|
Return on Assets (ttm)
|
-25.0 |
|
Return on Equity (ttm)
|
-92.6 |
|
Qtrly Rev. Growth
|
-53.1 |
|
Gross Profit (p.s.)
|
-0.519 |
|
Sales Per Share
|
0.017 |
|
EBITDA (p.s.)
|
-0.642 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-91 |
|
Levered Free Cash Flow (M)
|
-50 |
Stock Valuations |
|
PE Ratio
|
-18.49 |
|
PEG Ratio
|
|
|
Price to Book value
|
17.02 |
|
Price to Sales
|
1299.33 |
|
Price to Cash Flow
|
-37.33 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
